T1	Participants 70 108	regression of carotid atherosclerosis.
T2	Participants 184 207	subjects with diabetes.
T3	Participants 648 698	Hypercholesterolemic subjects with type 2 diabetes
T4	Participants 886 973	A total of 97 subjects (51 pitavastatin; 46 pravastatin) completed this 36-month study.
